Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$2.61 - $4.49 $772 - $1,329
-296 Reduced 0.85%
34,619 $98,000
Q4 2023

Feb 13, 2024

SELL
$1.97 - $4.21 $279 - $597
-142 Reduced 0.41%
34,915 $142,000
Q3 2023

Nov 13, 2023

BUY
$2.34 - $4.43 $2,915 - $5,519
1,246 Added 3.69%
35,057 $111,000
Q2 2023

Aug 04, 2023

SELL
$1.9 - $4.3 $834 - $1,887
-439 Reduced 1.28%
33,811 $112,000
Q1 2023

May 12, 2023

SELL
$1.89 - $2.93 $8,125 - $12,596
-4,299 Reduced 11.15%
34,250 $72,000
Q4 2022

Feb 10, 2023

SELL
$2.48 - $3.43 $746 - $1,032
-301 Reduced 0.77%
38,549 $103,000
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $4,490 - $9,194
1,430 Added 3.82%
38,850 $126,000
Q2 2022

Aug 12, 2022

SELL
$4.74 - $8.15 $8,901 - $15,305
-1,878 Reduced 4.78%
37,420 $183,000
Q1 2022

May 13, 2022

BUY
$6.47 - $9.57 $91,874 - $135,894
14,200 Added 56.58%
39,298 $299,000
Q4 2021

Feb 11, 2022

SELL
$9.02 - $13.5 $7,522 - $11,259
-834 Reduced 3.22%
25,098 $232,000
Q3 2021

Nov 12, 2021

BUY
$13.71 - $17.18 $1,494 - $1,872
109 Added 0.42%
25,932 $369,000
Q2 2021

Aug 13, 2021

BUY
$14.92 - $23.23 $172,490 - $268,562
11,561 Added 81.06%
25,823 $429,000
Q1 2021

May 07, 2021

BUY
$7.33 - $21.06 $2,250 - $6,465
307 Added 2.2%
14,262 $260,000
Q4 2020

Feb 12, 2021

BUY
$3.63 - $7.53 $6,722 - $13,945
1,852 Added 15.3%
13,955 $105,000
Q3 2020

Nov 04, 2020

SELL
$3.29 - $4.58 $908 - $1,264
-276 Reduced 2.23%
12,103 $47,000
Q2 2020

Aug 12, 2020

BUY
$2.86 - $4.61 $15,140 - $24,405
5,294 Added 74.72%
12,379 $48,000
Q1 2020

May 04, 2020

BUY
$2.92 - $5.31 $703 - $1,279
241 Added 3.52%
7,085 $23,000
Q4 2019

Feb 05, 2020

BUY
$4.7 - $8.11 $897 - $1,549
191 Added 2.87%
6,844 $33,000
Q3 2019

Nov 08, 2019

SELL
$3.57 - $8.09 $164 - $372
-46 Reduced 0.69%
6,653 $44,000
Q2 2019

Aug 13, 2019

BUY
$6.58 - $8.69 $44,079 - $58,214
6,699 New
6,699 $51,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $378M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.